Odyssey Therapeutics, Inc. (ODTX)
NASDAQ: ODTX · Real-Time Price · USD
25.41
+0.91 (3.69%)
Sep 2, 2026, 11:48 AM EDT - Market open
Odyssey Therapeutics Revenue
Odyssey Therapeutics had revenue of $99.00K in the twelve months ending June 30, 2026, down -96.70% year-over-year. In the year 2025, Odyssey Therapeutics had annual revenue of $2.98M, down -33.45%.
Revenue (ttm)
$99.00K
Revenue Growth
-96.70%
P/S Ratio
12,296.65
Revenue / Employee
$990
Employees
100
Market Cap
1.22B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.98M | -1.50M | -33.45% |
| Dec 31, 2024 | 4.47M | 3.44M | 331.24% |
| Dec 31, 2023 | 1.04M | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
ODTX News
- 6 days ago - Odyssey Therapeutics initiated with a Buy at H.C. Wainwright - TheFly
- 7 days ago - Odyssey Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 27 days ago - Evotec enters R&D collaboration with Odyssey Therapeutics - TheFly
- 27 days ago - Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases - PRNewsWire
- 4 weeks ago - Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Odyssey Therapeutics Earnings release: Q2 2026 - Filings
- 4 weeks ago - Odyssey Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Odyssey Therapeutics Slides: Corporate presentation - Filings